Capital Fund Management (CFM)’s PDL BioPharma, Inc. PDLI Stock Holding History

Capital Fund Management (CFM)’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-91,600	Closed	-$461K	–	1840
2015 Q3	$461K	Sell	91,600 -22,900	-20%	-$131K	0.01%	1066
2015 Q2	$736K	Buy	114,500 +97,700	+582%	+$654K	0.01%	927
2015 Q1	$118K	Buy	+16,800	New	+$122K	﹤0.01%	1389
2014 Q3	–	Sell	-12,400	Closed	-$120K	–	2066
2014 Q2	$120K	Buy	12,400 +2,164	+21%	+$19.3K	﹤0.01%	1617
2014 Q1	$85K	Buy	+10,236	New	+$87.7K	﹤0.01%	1650
2013 Q4	–	Sell	-73,878	Closed	-$589K	–	1997
2013 Q3	$589K	Sell	73,878 -399,822	-84%	-$3.21M	0.01%	1097
2013 Q2	$3.66M	Buy	+473,700	New	+$3.69M	0.06%	439

Other funds holding PDLI

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital Fund Management (CFM)'s PDLI Position: Q4 2015 in Review

Capital Fund Management (CFM) sold out of PDL BioPharma, Inc. (PDLI) in Q4 2015, closing a stake of 91,600 shares — an estimated $461K sold.

Capital Fund Management (CFM) first reported a position in PDLI in Q2 2013 and held it in 7 quarters. The position peaked at $3.66M in Q2 2013. 204 funds tracked by Wall St. Rank hold PDLI as of Q4 2015.

Capital Fund Management (CFM) reported no remaining PDL BioPharma, Inc. position as of Q4 2015 after selling out during the quarter.
Capital Fund Management (CFM) sold 91,600 PDL BioPharma, Inc. shares in Q4 2015, an estimated $461K.
Capital Fund Management (CFM) first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 7 quarters.
Capital Fund Management (CFM)'s PDL BioPharma, Inc. position peaked at $3.66M in Q2 2013.
204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2015.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2015, filed 28 Jan 2016.